These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6221529

  • 1. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives.
    Tai HH, Lee N, Tai CL.
    Adv Prostaglandin Thromboxane Res; 1980; 6():447-52. PubMed ID: 7189951
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iizuka K.
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract] [Full Text] [Related]

  • 5. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR.
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of human platelet thromboxane synthetase by 11a-carbathromboxane A2 analogs.
    Gorman RR, Maxey KM, Bundy GL.
    Biochem Biophys Res Commun; 1981 May 15; 100(1):184-90. PubMed ID: 7196228
    [No Abstract] [Full Text] [Related]

  • 7. Imidazo[1,5-a]pyridines: a new class of thromboxane A2 synthetase inhibitors.
    Ford NF, Browne LJ, Campbell T, Gemenden C, Goldstein R, Gude C, Wasley JW.
    J Med Chem; 1985 Feb 15; 28(2):164-70. PubMed ID: 3918169
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of thromboxane synthetase inhibitors.
    Smith JB.
    Fed Proc; 1987 Jan 15; 46(1):139-43. PubMed ID: 3542573
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD, Hamilton JG.
    Adv Prostaglandin Thromboxane Res; 1980 Jan 15; 6():453-6. PubMed ID: 6770605
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the biological activity of azoprostanoids in human platelets.
    Gorman RR, Shebuski RJ, Aiken JW, Bundy GL.
    Fed Proc; 1981 May 15; 40(7):1997-2000. PubMed ID: 7014259
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of platelet aggregation by 1-alkylimidazole derivatives, thromboxane A synthetase inhibitors.
    Kayama N, Sakaguchi K, Kaneko S, Kubota T, Fukuzawa T, Kawamura S, Yoshimoto T, Yamamoto S.
    Prostaglandins; 1981 Apr 15; 21(4):543-54. PubMed ID: 7196056
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD, Lakin KM, Mevkh AT, Novikova NV, Rukazenkov IuZ.
    Dokl Akad Nauk SSSR; 1985 Apr 15; 282(1):194-6. PubMed ID: 3928305
    [No Abstract] [Full Text] [Related]

  • 14. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor.
    Bertelé V, Falanga A, Tomasiak M, Cerletti C, de Gaetano G.
    Thromb Haemost; 1984 Feb 28; 51(1):125-8. PubMed ID: 6326343
    [Abstract] [Full Text] [Related]

  • 15. Platelet thromboxane synthetase inhibitors with low doses of aspirin: possible resolution of the "aspirin dilemma".
    Bertelé V, Falanga A, Tomasiak M, Dejana E, Cerletti C, de Gaetano G.
    Science; 1983 Apr 29; 220(4596):517-9. PubMed ID: 6682245
    [Abstract] [Full Text] [Related]

  • 16. Different effects of thromboxane synthetase inhibitors on platelets from different individuals.
    Lancet; 1982 Nov 20; 2(8308):1156-7. PubMed ID: 6128469
    [No Abstract] [Full Text] [Related]

  • 17. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V, Falanga A, Roncaglioni MC, Cerletti C, de Gaetano G.
    Thromb Haemost; 1982 Jun 28; 47(3):294. PubMed ID: 7051411
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.